Table 4.
Biomarkers observed in patients with COVID-19 in the first week of hospitalization.
| Parameters | Overall n = 176 | Hospital discharge n = 155 | Deaths n = 21 | p-value | Relative risk (CI 95%) |
|---|---|---|---|---|---|
| Clinical (n.) | |||||
| Oxygen saturation Mean ± SD | 90.90 (±3.549) | 91.11 (±3.434) | 88.40 (±4.083) | 0.0933 | – |
| Fever | 114 | 101 | 13 | 0.7694 | 0.8838 (0.4000–1.994) |
| Dry cough | 116 | 101 | 15 | 0.5696 | 1.293 (0.5529–3.118) |
| Cough with secretion | 31 | 26 | 5 | 0.5399 | 1.462 (0.5790–3.440) |
| Coryza | 48 | 40 | 8 | 0.2354 | 1.641 (0.7299–3.580) |
| Shortness of breathe | 77 | 69 | 8 | 0.5778 | 0.7912 (0.3506–1.761) |
| Weakness | 132 | 116 | 16 | 0.8932 | 1.067 (0.4408–2.711) |
| Smell disorders | 49 | 43 | 6 | 0.9366 | 1.037 (0.4308–2.400) |
| Taste disorder | 25 | 22 | 3 | 0.9999 | 0.9537 (0.3101–2.642) |
| Sore throat | 27 | 23 | 4 | 0.5359 | 1.298 (0.4752–3.250) |
| Diarrhea | 55 | 50 | 5 | 0.6165 | 0.6875 (0.2698–1.686) |
| Nausea and vomiting | 51 | 42 | 9 | 0.1352 | 1.838 (0.8317–3.970) |
Data are presented as median (minimum–maximum and interquartile range). A two-tailed p-value of ≤ 0.05 was considered significant.